Industry Research Reports
Home > Reports > Food & Beverages > Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2031
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Food & Beverages
Published Date: 2025-07-31
Pages: 158 Pages
Report ld: 4816334
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
OPO-containing Infant Formulas Market Size(US$)
CAGR 2025-2031
5.0%
Market Size,2031
USD 1,497
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,117 million
Market Forecast in 2031(Value)
US$ 1,497 million
CAGR
5.0%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
OPO-containing infant formulas are specialized formulas enriched with structured triglycerides, predominantly 1,3-dioleoyl-2-palmitoylglycerol (OPO), designed to mimic the fat structure of human breast milk. OPO enhances the bioavailability of palmitic acid in a way that promotes better fat and calcium absorption, reducing the risk of constipation and improving stool consistency in infants. Key features include a balanced lipid profile, enhanced digestibility, and a role in supporting gut health by fostering beneficial microbiota. These formulas are particularly beneficial for infants who cannot be breastfed, offering improved energy utilization, growth support, and comfort in digestion, making them suitable for addressing feeding issues and ensuring optimal nutrient uptake.
From a downstream perspective, 0 - 6 Month accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
OPO-containing Infant Formulas leading manufacturers including BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, etc., dominate supply; the top five capture approximately % of global revenue, with BiosTime leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global OPO-containing Infant Formulas market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- BiosTime
- Nutriben
- Ausnutria
- HERDS
- Milupa
- Shanxi Yatai
- Beingmate
- Abbott
- Brightdairy
- Feihe
- Wyeth Nutrition
- Deloraine
- Yili
- Kabrita
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cow Milk Formula
- Goat Milk Formula
Segment by Application
- 0 - 6 Month
- 6 - 12 Month
- 12 - 36 Month
CHAPTER OUTLINE
Chapter 1: Defines the OPO-containing Infant Formulas study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to OPO-containing Infant Formulas: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global OPO-containing Infant Formulas Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cow Milk Formula
1.2.3 Goat Milk Formula
1.3 Market Segmentation by Application
1.3.1 Global OPO-containing Infant Formulas Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 0 - 6 Month
1.3.3 6 - 12 Month
1.3.4 12 - 36 Month
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global OPO-containing Infant Formulas Revenue Estimates and Forecasts 2020-2031
2.2 Global OPO-containing Infant Formulas Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global OPO-containing Infant Formulas Sales Estimates and Forecasts 2020-2031
2.4 Global OPO-containing Infant Formulas Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global OPO-containing Infant Formulas Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global OPO-containing Infant Formulas Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Cow Milk Formula Market Size by Manufacturers
3.5.2 Goat Milk Formula Market Size by Manufacturers
3.6 Global OPO-containing Infant Formulas Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global OPO-containing Infant Formulas Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global OPO-containing Infant Formulas Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global OPO-containing Infant Formulas Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global OPO-containing Infant Formulas Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America OPO-containing Infant Formulas Sales and Revenue by Type (2020-2031)
6.4 North America OPO-containing Infant Formulas Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America OPO-containing Infant Formulas Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe OPO-containing Infant Formulas Sales and Revenue by Type (2020-2031)
7.4 Europe OPO-containing Infant Formulas Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe OPO-containing Infant Formulas Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific OPO-containing Infant Formulas Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific OPO-containing Infant Formulas Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific OPO-containing Infant Formulas Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America OPO-containing Infant Formulas Sales and Revenue by Type (2020-2031)
9.4 Central and South America OPO-containing Infant Formulas Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America OPO-containing Infant Formulas Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa OPO-containing Infant Formulas Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa OPO-containing Infant Formulas Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa OPO-containing Infant Formulas Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BiosTime
11.1.1 BiosTime Corporation Information
11.1.2 BiosTime Business Overview
11.1.3 BiosTime OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.1.4 BiosTime OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 BiosTime OPO-containing Infant Formulas Sales by Product in 2024
11.1.6 BiosTime OPO-containing Infant Formulas Sales by Application in 2024
11.1.7 BiosTime OPO-containing Infant Formulas Sales by Geographic Area in 2024
11.1.8 BiosTime OPO-containing Infant Formulas SWOT Analysis
11.1.9 BiosTime Recent Developments
11.2 Nutriben
11.2.1 Nutriben Corporation Information
11.2.2 Nutriben Business Overview
11.2.3 Nutriben OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.2.4 Nutriben OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Nutriben OPO-containing Infant Formulas Sales by Product in 2024
11.2.6 Nutriben OPO-containing Infant Formulas Sales by Application in 2024
11.2.7 Nutriben OPO-containing Infant Formulas Sales by Geographic Area in 2024
11.2.8 Nutriben OPO-containing Infant Formulas SWOT Analysis
11.2.9 Nutriben Recent Developments
11.3 Ausnutria
11.3.1 Ausnutria Corporation Information
11.3.2 Ausnutria Business Overview
11.3.3 Ausnutria OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.3.4 Ausnutria OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Ausnutria OPO-containing Infant Formulas Sales by Product in 2024
11.3.6 Ausnutria OPO-containing Infant Formulas Sales by Application in 2024
11.3.7 Ausnutria OPO-containing Infant Formulas Sales by Geographic Area in 2024
11.3.8 Ausnutria OPO-containing Infant Formulas SWOT Analysis
11.3.9 Ausnutria Recent Developments
11.4 HERDS
11.4.1 HERDS Corporation Information
11.4.2 HERDS Business Overview
11.4.3 HERDS OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.4.4 HERDS OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 HERDS OPO-containing Infant Formulas Sales by Product in 2024
11.4.6 HERDS OPO-containing Infant Formulas Sales by Application in 2024
11.4.7 HERDS OPO-containing Infant Formulas Sales by Geographic Area in 2024
11.4.8 HERDS OPO-containing Infant Formulas SWOT Analysis
11.4.9 HERDS Recent Developments
11.5 Milupa
11.5.1 Milupa Corporation Information
11.5.2 Milupa Business Overview
11.5.3 Milupa OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.5.4 Milupa OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Milupa OPO-containing Infant Formulas Sales by Product in 2024
11.5.6 Milupa OPO-containing Infant Formulas Sales by Application in 2024
11.5.7 Milupa OPO-containing Infant Formulas Sales by Geographic Area in 2024
11.5.8 Milupa OPO-containing Infant Formulas SWOT Analysis
11.5.9 Milupa Recent Developments
11.6 Shanxi Yatai
11.6.1 Shanxi Yatai Corporation Information
11.6.2 Shanxi Yatai Business Overview
11.6.3 Shanxi Yatai OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.6.4 Shanxi Yatai OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Shanxi Yatai Recent Developments
11.7 Beingmate
11.7.1 Beingmate Corporation Information
11.7.2 Beingmate Business Overview
11.7.3 Beingmate OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.7.4 Beingmate OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Beingmate Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Business Overview
11.8.3 Abbott OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.8.4 Abbott OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Abbott Recent Developments
11.9 Brightdairy
11.9.1 Brightdairy Corporation Information
11.9.2 Brightdairy Business Overview
11.9.3 Brightdairy OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.9.4 Brightdairy OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Brightdairy Recent Developments
11.10 Feihe
11.10.1 Feihe Corporation Information
11.10.2 Feihe Business Overview
11.10.3 Feihe OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.10.4 Feihe OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Feihe Recent Developments
11.11 Wyeth Nutrition
11.11.1 Wyeth Nutrition Corporation Information
11.11.2 Wyeth Nutrition Business Overview
11.11.3 Wyeth Nutrition OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.11.4 Wyeth Nutrition OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Wyeth Nutrition Recent Developments
11.12 Deloraine
11.12.1 Deloraine Corporation Information
11.12.2 Deloraine Business Overview
11.12.3 Deloraine OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.12.4 Deloraine OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Deloraine Recent Developments
11.13 Yili
11.13.1 Yili Corporation Information
11.13.2 Yili Business Overview
11.13.3 Yili OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.13.4 Yili OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Yili Recent Developments
11.14 Kabrita
11.14.1 Kabrita Corporation Information
11.14.2 Kabrita Business Overview
11.14.3 Kabrita OPO-containing Infant Formulas Product Models, Descriptions and Specifications
11.14.4 Kabrita OPO-containing Infant Formulas Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Kabrita Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 OPO-containing Infant Formulas Industry Chain
12.2 OPO-containing Infant Formulas Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 OPO-containing Infant Formulas Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 OPO-containing Infant Formulas Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 OPO-containing Infant Formulas Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global OPO-containing Infant Formulas Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global OPO-containing Infant Formulas Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global OPO-containing Infant Formulas Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global OPO-containing Infant Formulas Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global OPO-containing Infant Formulas Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global OPO-containing Infant Formulas Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global OPO-containing Infant Formulas Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 7. Global OPO-containing Infant Formulas Sales by Region (2020-2025) & (K MT)
Table 8. Global OPO-containing Infant Formulas Sales by Region (2026-2031) & (K MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global OPO-containing Infant Formulas Sales by Manufacturers (2020-2025) & (K MT)
Table 11. Global OPO-containing Infant Formulas Sales Share by Manufacturers (2020-2025)
Table 12. Global OPO-containing Infant Formulas Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global OPO-containing Infant Formulas Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global OPO-containing Infant Formulas by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OPO-containing Infant Formulas as of 2024)
Table 16. Global OPO-containing Infant Formulas Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global OPO-containing Infant Formulas Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 18. Key Manufacturers OPO-containing Infant Formulas Manufacturing Base and Headquarters
Table 19. Global OPO-containing Infant Formulas Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global OPO-containing Infant Formulas Sales by Type (2020-2025) & (K MT)
Table 23. Global OPO-containing Infant Formulas Sales by Type (2026-2031) & (K MT)
Table 24. Global OPO-containing Infant Formulas Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global OPO-containing Infant Formulas Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global OPO-containing Infant Formulas ASP by Type (2020-2031) & (USD/MT)
Table 27. Technical Specifications by Key Product Type
Table 28. Global OPO-containing Infant Formulas Sales by Application (2020-2025) & (K MT)
Table 29. Global OPO-containing Infant Formulas Sales by Application (2026-2031) & (K MT)
Table 30. OPO-containing Infant Formulas High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global OPO-containing Infant Formulas Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global OPO-containing Infant Formulas Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global OPO-containing Infant Formulas ASP by Application (2020-2031) & (USD/MT)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America OPO-containing Infant Formulas Growth Accelerators and Market Barriers
Table 37. North America OPO-containing Infant Formulas Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America OPO-containing Infant Formulas Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 39. Europe OPO-containing Infant Formulas Growth Accelerators and Market Barriers
Table 40. Europe OPO-containing Infant Formulas Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe OPO-containing Infant Formulas Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific OPO-containing Infant Formulas Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific OPO-containing Infant Formulas Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific OPO-containing Infant Formulas Growth Accelerators and Market Barriers
Table 45. Southeast Asia OPO-containing Infant Formulas Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America OPO-containing Infant Formulas Investment Opportunities and Key Challenges
Table 47. Central and South America OPO-containing Infant Formulas Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa OPO-containing Infant Formulas Investment Opportunities and Key Challenges
Table 49. Middle East and Africa OPO-containing Infant Formulas Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. BiosTime Corporation Information
Table 51. BiosTime Description and Major Businesses
Table 52. BiosTime Product Models, Descriptions and Specifications
Table 53. BiosTime Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 54. BiosTime Sales Value Proportion by Product in 2024
Table 55. BiosTime Sales Value Proportion by Application in 2024
Table 56. BiosTime Sales Value Proportion by Geographic Area in 2024
Table 57. BiosTime OPO-containing Infant Formulas SWOT Analysis
Table 58. BiosTime Recent Developments
Table 59. Nutriben Corporation Information
Table 60. Nutriben Description and Major Businesses
Table 61. Nutriben Product Models, Descriptions and Specifications
Table 62. Nutriben Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Nutriben Sales Value Proportion by Product in 2024
Table 64. Nutriben Sales Value Proportion by Application in 2024
Table 65. Nutriben Sales Value Proportion by Geographic Area in 2024
Table 66. Nutriben OPO-containing Infant Formulas SWOT Analysis
Table 67. Nutriben Recent Developments
Table 68. Ausnutria Corporation Information
Table 69. Ausnutria Description and Major Businesses
Table 70. Ausnutria Product Models, Descriptions and Specifications
Table 71. Ausnutria Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 72. Ausnutria Sales Value Proportion by Product in 2024
Table 73. Ausnutria Sales Value Proportion by Application in 2024
Table 74. Ausnutria Sales Value Proportion by Geographic Area in 2024
Table 75. Ausnutria OPO-containing Infant Formulas SWOT Analysis
Table 76. Ausnutria Recent Developments
Table 77. HERDS Corporation Information
Table 78. HERDS Description and Major Businesses
Table 79. HERDS Product Models, Descriptions and Specifications
Table 80. HERDS Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. HERDS Sales Value Proportion by Product in 2024
Table 82. HERDS Sales Value Proportion by Application in 2024
Table 83. HERDS Sales Value Proportion by Geographic Area in 2024
Table 84. HERDS OPO-containing Infant Formulas SWOT Analysis
Table 85. HERDS Recent Developments
Table 86. Milupa Corporation Information
Table 87. Milupa Description and Major Businesses
Table 88. Milupa Product Models, Descriptions and Specifications
Table 89. Milupa Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Milupa Sales Value Proportion by Product in 2024
Table 91. Milupa Sales Value Proportion by Application in 2024
Table 92. Milupa Sales Value Proportion by Geographic Area in 2024
Table 93. Milupa OPO-containing Infant Formulas SWOT Analysis
Table 94. Milupa Recent Developments
Table 95. Shanxi Yatai Corporation Information
Table 96. Shanxi Yatai Description and Major Businesses
Table 97. Shanxi Yatai Product Models, Descriptions and Specifications
Table 98. Shanxi Yatai Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 99. Shanxi Yatai Recent Developments
Table 100. Beingmate Corporation Information
Table 101. Beingmate Description and Major Businesses
Table 102. Beingmate Product Models, Descriptions and Specifications
Table 103. Beingmate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Beingmate Recent Developments
Table 105. Abbott Corporation Information
Table 106. Abbott Description and Major Businesses
Table 107. Abbott Product Models, Descriptions and Specifications
Table 108. Abbott Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 109. Abbott Recent Developments
Table 110. Brightdairy Corporation Information
Table 111. Brightdairy Description and Major Businesses
Table 112. Brightdairy Product Models, Descriptions and Specifications
Table 113. Brightdairy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 114. Brightdairy Recent Developments
Table 115. Feihe Corporation Information
Table 116. Feihe Description and Major Businesses
Table 117. Feihe Product Models, Descriptions and Specifications
Table 118. Feihe Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 119. Feihe Recent Developments
Table 120. Wyeth Nutrition Corporation Information
Table 121. Wyeth Nutrition Description and Major Businesses
Table 122. Wyeth Nutrition Product Models, Descriptions and Specifications
Table 123. Wyeth Nutrition Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 124. Wyeth Nutrition Recent Developments
Table 125. Deloraine Corporation Information
Table 126. Deloraine Description and Major Businesses
Table 127. Deloraine Product Models, Descriptions and Specifications
Table 128. Deloraine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 129. Deloraine Recent Developments
Table 130. Yili Corporation Information
Table 131. Yili Description and Major Businesses
Table 132. Yili Product Models, Descriptions and Specifications
Table 133. Yili Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 134. Yili Recent Developments
Table 135. Kabrita Corporation Information
Table 136. Kabrita Description and Major Businesses
Table 137. Kabrita Product Models, Descriptions and Specifications
Table 138. Kabrita Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 139. Kabrita Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. OPO-containing Infant Formulas Product Picture
Figure 2. Global OPO-containing Infant Formulas Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Cow Milk Formula Product Picture
Figure 4. Goat Milk Formula Product Picture
Figure 5. Global OPO-containing Infant Formulas Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. 0 - 6 Month
Figure 7. 6 - 12 Month
Figure 8. 12 - 36 Month
Figure 9. OPO-containing Infant Formulas Report Years Considered
Figure 10. Global OPO-containing Infant Formulas Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 12. Global OPO-containing Infant Formulas Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global OPO-containing Infant Formulas Revenue Market Share by Region (2020-2031)
Figure 14. Global OPO-containing Infant Formulas Sales (2020-2031) & (K MT)
Figure 15. Global OPO-containing Infant Formulas Sales (CAGR) by Region (2020-2031) (K MT)
Figure 16. Global OPO-containing Infant Formulas Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers OPO-containing Infant Formulas Sales Volume Market Share in 2024
Figure 18. Global OPO-containing Infant Formulas Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Cow Milk Formula Revenue Market Share by Manufacturer in 2024
Figure 21. Goat Milk Formula Revenue Market Share by Manufacturer in 2024
Figure 22. Global OPO-containing Infant Formulas Sales Market Share by Type (2020-2031)
Figure 23. Global OPO-containing Infant Formulas Revenue Market Share by Type (2020-2031)
Figure 24. Global OPO-containing Infant Formulas Sales Market Share by Application (2020-2031)
Figure 25. Global OPO-containing Infant Formulas Revenue Market Share by Application (2020-2031)
Figure 26. North America OPO-containing Infant Formulas Sales YoY (2020-2031) & (K MT)
Figure 27. North America OPO-containing Infant Formulas Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers OPO-containing Infant Formulas Sales Revenue (US$ Million) in 2024
Figure 29. North America OPO-containing Infant Formulas Sales Volume (K MT) by Type (2020- 2031)
Figure 30. North America OPO-containing Infant Formulas Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America OPO-containing Infant Formulas Sales Volume (K MT) by Application (2020-2031)
Figure 32. North America OPO-containing Infant Formulas Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 34. Canada OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 36. Europe OPO-containing Infant Formulas Sales YoY (2020-2031) & (K MT)
Figure 37. Europe OPO-containing Infant Formulas Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers OPO-containing Infant Formulas Sales Revenue (US$ Million) in 2024
Figure 39. Europe OPO-containing Infant Formulas Sales Volume (K MT) by Type (2020-2031)
Figure 40. Europe OPO-containing Infant Formulas Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe OPO-containing Infant Formulas Sales Volume (K MT) by Application (2020-2031)
Figure 42. Europe OPO-containing Infant Formulas Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 44. France OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 46. Italy OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 47. Russia OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific OPO-containing Infant Formulas Sales YoY (2020-2031) & (K MT)
Figure 49. Asia-Pacific OPO-containing Infant Formulas Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers OPO-containing Infant Formulas Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific OPO-containing Infant Formulas Sales Volume (K MT) by Type (2020- 2031)
Figure 52. Asia-Pacific OPO-containing Infant Formulas Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific OPO-containing Infant Formulas Sales Volume (K MT) by Application (2020-2031)
Figure 54. Asia-Pacific OPO-containing Infant Formulas Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 56. Japan OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 59. India OPO-containing Infant Formulas Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America OPO-containing Infant Formulas Sales YoY (2020-2031) & (K MT)
Figure 61. Central and South America OPO-containing Infant Formulas Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers OPO-containing Infant Formulas Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America OPO-containing Infant Formulas Sales Volume (K MT) by Type (2021-2031)
Figure 64. Central and South America OPO-containing Infant Formulas Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America OPO-containing Infant Formulas Sales Volume (K MT) by Application (2020-2031)
Figure 66. Central and South America OPO-containing Infant Formulas Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil OPO-containing Infant Formulas Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina OPO-containing Infant Formulas Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa OPO-containing Infant Formulas Sales YoY (2020-2031) & (K MT)
Figure 70. Middle East and Africa OPO-containing Infant Formulas Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers OPO-containing Infant Formulas Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa OPO-containing Infant Formulas Sales Volume (K MT) by Type (2021-2031)
Figure 73. South America OPO-containing Infant Formulas Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa OPO-containing Infant Formulas Sales Volume (K MT) by Application (2020-2031)
Figure 75. Middle East and Africa OPO-containing Infant Formulas Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries OPO-containing Infant Formulas Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey OPO-containing Infant Formulas Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt OPO-containing Infant Formulas Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa OPO-containing Infant Formulas Revenue (2020-2025) & (US$ Million)
Figure 80. OPO-containing Infant Formulas Industry Chain Mapping
Figure 81. Regional OPO-containing Infant Formulas Manufacturing Base Distribution (%)
Figure 82. Global OPO-containing Infant Formulas Production Market Share by Region (2020-2031)
Figure 83. OPO-containing Infant Formulas Production Process
Figure 84. Regional OPO-containing Infant Formulas Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global OPO-containing Infant Formulas market?
The top companies in the global OPO-containing Infant Formulas market are BiosTime、Nutriben、Ausnutria.
What is the annual compound growth rate of the global OPO-containing Infant Formulas market size from 2025 to 2031?
What was the global market size of OPO-containing Infant Formulas in 2031?
Which region is expected to have the highest market share?
What was the global market size of OPO-containing Infant Formulas in 2025?
Related Reports
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2032
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 157
USD 4900.00
(Single User License)
Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 94
USD 4250.00
(Single User License)
OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2026
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 125
USD 2900.00
(Single User License)
Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 96
USD 4250.00
(Single User License)
OPO-containing Infant Formulas - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 118
USD 3950.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2025
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-03-13
Pages: 93
USD 2900.00
(Single User License)
OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 112
USD 3950.00
(Single User License)
Global OPO-containing Infant Formulas Market Insights, Forecast to 2030
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 165
USD 4900.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2024
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 89
USD 2900.00
(Single User License)
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2032
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 157
USD 4900.00 (Single User License)Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 94
USD 4250.00 (Single User License)OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
USD 3950.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2026
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 125
USD 2900.00 (Single User License)Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 96
USD 4250.00 (Single User License)OPO-containing Infant Formulas - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 118
USD 3950.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2025
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-03-13
Pages: 93
USD 2900.00 (Single User License)OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 112
USD 3950.00 (Single User License)Global OPO-containing Infant Formulas Market Insights, Forecast to 2030
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 165
USD 4900.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2024
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 89
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now